To: All Faculty, Staff and Students
From: Richard C. Levin
Summary: Announcement - University Health Services
|Date: 30-APR-2012 04:05:00 PM
||Message ID: 78615
|To the Yale University Community:|
I write with great pleasure to inform you that Paul Genecin has agreed to continue as Director of University Health Services for a five-year term, effective July 1, 2012.
I extend my gratitude to all of those who wrote or talked to Dr. Stephanie Spangler, Deputy Provost for Health Affairs and Academic Integrity, regarding the state of the University Health Services and its leadership. Dr. Genecin received enthusiastic support and all agree that the organization has been transformed under his dedicated and thoughtful leadership. Those who work with Dr. Genecin call him an exceptional listener who is willing to tackle difficult issues. He cares deeply about his staff, his patients, and the wider university community, and has effectively engaged each of these constituencies. Among his many accomplishments, Dr. Genecin orchestrated the highly complex move to the new state-of-the-art Yale Health Center at 55 Lock Street, with virtually no disruption in patient care.
The National Committee for Quality Assurance recently recognized our health service as a model of 21st century primary care by awarding a perfect score for its accomplishments as a Patient-Centered Medical Home (PCMH). The PCMH model is positioned to be one of the transformational components of health care reform nationally. Dr. Genecin credits the hard work of our employees in attaining this outstanding recognition.
In the years ahead, Dr. Genecin and his colleagues plan to work to fortify their attention to patient experience at Yale and to keep the University on the cutting edge of excellent and innovative health care delivery in the ever-evolving health care reform environment. Another priority will be to strengthen relationships and collaborations with Yale partners including the School of Medicine and School of Nursing.
The Yale community is fortunate to have the services of such an outstanding leader. I know that you join me in thanking Dr. Genecin for his willingness to serve for a fourth term as Director.
Richard C. Levin